Filing Details
- Accession Number:
- 0001209191-22-008979
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-11 18:07:55
- Reporting Period:
- 2022-02-09
- Accepted Time:
- 2022-02-11 18:07:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1595893 | Turning Point Therapeutics Inc. | TPTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1571469 | Athena Countouriotis | 10628 Science Center Drive San Diego CA 92121 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-02-09 | 2,971 | $36.30 | 47,930 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-02-09 | 62,400 | $0.00 | 110,330 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2022-02-09 | 224,640 | $0.00 | 224,640 | $37.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 224,640 | 2032-02-08 | No | 4 | A | Direct |
Footnotes
- Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on February 8, 2021.
- The Reporting Person acquired 706 shares on June 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan (the "ESPP").
- Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
- 1/48th of the shares vest monthly following February 9, 2022.
Billionaire Hedge Funds
